ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 344

Non Classical Monocytes Are Required for Initiation Phase While Macrophages Are Necessary for the Resolution Phase in the K/BxN Murine of Inflammatory Arthritis

Alexander V. Misharin1, G. Kenneth Haines III2 and Harris R. Perlman3, 1Medicine/Rheumatology, Northwestern University, Chicago, IL, 2Department of Pathology, Yale University, New Haven, CT, 3Feinberg School of Medicine, Northwestern University, Chicago, IL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: macrophages, monocytes and neutrophils

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis: Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Monocytes and macrophages play an essential function in the pathogenesis of rheumatoid arthritis. However, monocytes and macrophages are a heterogenous population and thus the role that the individual subsets play in the initiation, perpetuation and/or resolution phases of inflammatory arthritis is unknown.  Here we utilized strategies to deplete selective populations of monocyte and macrophage subsets but not neutrophils, to uncover the role of these cells in the development and resolution phases of arthritis.

Methods: C57BL/6 and CD11b-DTR transgenic mice were used in the study. Conditional monocyte/macrophage ablation was induced by repetitive administration of diphtheria toxin (DT) into CD11b-DTR transgenic mice during initiation and resolution phases of inflammatory arthritis.  Selective depletion of classic Ly6C+CCR2+ monocyte subset was achieved via administration of anti-CCR2 antibody during initiation and resolution phases of inflammatory arthritis.  Arthritis was induced using K/BxN serum transfer model and its severity was assessed using the clinical and histological scoring systems.

Results: Mice pretreated with DT and every three days for 14 days exhibited reduced numbers of peripheral blood monocytes but had no change in neutrophils. Subsequently, these mice initially developed K/BxN serum transfer induced arthritis but the arthritis was short lived and reached only a very moderate severity.  An additional study was also performed, which entailed the administration of DT at day 7 and every 3 days until days 14-17 following the initial injection of K/BxN serum. Surprisingly, deletion of monocytes and synovial macrophages markedly delayed the resolution phase of the K/BxN serum transfer induced arthritis.  In contrast, depletion of classic monocytes during both progressive phase and resolution of arthritis did not affect development or resolution of arthritis.

Conclusion: These data suggest a dual role for monocytes/macrophages in inflammatory arthritis that may be mediated by the local milieu.  Thus, macrophages in the joint may initially function as one of central inflammatory mediators of the destructive arthritis, while their phenotype may be polarized to a wound healing or regulatory type macrophage during the resolution of arthritis. The fact that classic monocytes were dispensable for both initiation and resolution of arthritis is of special interest, since most of the macrophages in the arthritis joint are monocyte derived. Taken together, these data indicate that targeting monocytes and macrophages as single type of monocyte/macrophage may not be therapeutically beneficial. Future therapies that identify the crucial type of macrophage at each stage of disease will lead to the development of novel therapeutics for RA.


Disclosure:

A. V. Misharin,
None;

G. K. Haines III,
None;

H. R. Perlman,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/non-classical-monocytes-are-required-for-initiation-phase-while-macrophages-are-necessary-for-the-resolution-phase-in-the-kbxn-murine-of-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology